124 related articles for article (PubMed ID: 23818807)
21. Intravenous thrombolysis for acute ischemic stroke occurring during hospitalization for transient ischemic attack.
Tsivgoulis G; Sharma VK; Mikulik R; Krogias C; Haršány M; Bavarsad Shahripour R; Athanasiadis D; Teoh HL; Piperidou C; Alexandrov AV
Int J Stroke; 2014 Jun; 9(4):413-8. PubMed ID: 23981541
[TBL] [Abstract][Full Text] [Related]
22. Establishment of primary stroke centers: a survey of physician attitudes and hospital resources.
Kidwell CS; Shephard T; Tonn S; Lawyer B; Murdock M; Koroshetz W; Alberts M; Hademenos GJ; Saver JL
Neurology; 2003 May; 60(9):1452-6. PubMed ID: 12743230
[TBL] [Abstract][Full Text] [Related]
23. The correlation between admission blood glucose and intravenous rt-PA-induced arterial recanalization in acute ischemic stroke: a multi-centre TCD study.
Saqqur M; Shuaib A; Alexandrov AV; Sebastian J; Khan K; Uchino K
Int J Stroke; 2015 Oct; 10(7):1087-92. PubMed ID: 26332252
[TBL] [Abstract][Full Text] [Related]
24. Agreement with evidence for tissue Plasminogen Activator use among emergency physicians: a cross-sectional survey.
Grady AM; Bryant J; Carey ML; Paul CL; Sanson-Fisher RW; Levi CR
BMC Res Notes; 2015 Jun; 8():267. PubMed ID: 26111807
[TBL] [Abstract][Full Text] [Related]
25. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS).
Hacke W; Kaste M; Fieschi C; Toni D; Lesaffre E; von Kummer R; Boysen G; Bluhmki E; Höxter G; Mahagne MH
JAMA; 1995 Oct; 274(13):1017-25. PubMed ID: 7563451
[TBL] [Abstract][Full Text] [Related]
26. Nonatrial Fibrillation was Associated With Early Neurological Improvement After Intravenous Thrombolysis With rt-PA in Patients With Acute Ischemic Stroke.
Liu J; Huang J; Xu H; Dai H
Neurologist; 2020 Mar; 25(2):28-32. PubMed ID: 32132497
[TBL] [Abstract][Full Text] [Related]
27. Barriers to administering intravenous tissue plasminogen activator (tPA) for acute ischemic stroke in the emergency department: A cross-sectional survey of stroke centers.
Hargis M; Shah JN; Mazabob J; Rao CV; Suarez JI; Bershad EM
Clin Neurol Neurosurg; 2015 Aug; 135():79-84. PubMed ID: 26047090
[TBL] [Abstract][Full Text] [Related]
28. Attitudes and current practice of primary care physicians in acute stroke management.
Roebers S; Wagner M; Ritter MA; Dornbach F; Wahle K; Heuschmann PU
Stroke; 2007 Apr; 38(4):1298-303. PubMed ID: 17332456
[TBL] [Abstract][Full Text] [Related]
29. Shenzhen stroke emergency map improves access to rt-PA for patients with acute ischaemic stroke.
Ye S; Hu S; Lei Z; Li Z; Li W; Sui Y; Ren L
Stroke Vasc Neurol; 2019 Sep; 4(3):115-122. PubMed ID: 31709116
[TBL] [Abstract][Full Text] [Related]
30. Informed Consent for Intravenous Tissue Plasminogen Activator in New York State Designated Stroke Centers.
Weintraub MI; Colello AD; Johnson SA; McClellan F; Cole SP; Benesch C; Rudolph SH; Levine SR
J Stroke Cerebrovasc Dis; 2017 Jun; 26(6):1274-1279. PubMed ID: 28189569
[TBL] [Abstract][Full Text] [Related]
31. Thrombolysis for acute ischemic stroke in Joint Commission-certified and -noncertified hospitals in Michigan.
Rajamani K; Millis S; Watson S; Mada F; Salowich-Palm L; Hinton S; Chaturvedi S
J Stroke Cerebrovasc Dis; 2013 Jan; 22(1):49-54. PubMed ID: 21852156
[TBL] [Abstract][Full Text] [Related]
32. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.
Clark WM; Wissman S; Albers GW; Jhamandas JH; Madden KP; Hamilton S
JAMA; 1999 Dec; 282(21):2019-26. PubMed ID: 10591384
[TBL] [Abstract][Full Text] [Related]
33. The risk factors of early hemorrhage after emergency intravenous thrombolysis in patients with acute ischemic stroke.
Zhang X; Yu Y; Jiang L; Chen T; Sang Y; Wang Y; Ren Y; Mao G; Gu Y; Shen H; Lu J
Ann Palliat Med; 2021 May; 10(5):5706-5713. PubMed ID: 34107714
[TBL] [Abstract][Full Text] [Related]
34. Influence of neurologists' experience on the outcome of patients treated by intravenous thrombolysis for cerebral ischaemia.
Tuffal A; Moulin S; Dequatre-Ponchelle N; Bodenant M; Dumont F; Lefebvre C; Hénon H; Debette S; Cordonnier C; Leys D
J Neurol; 2015 May; 262(5):1209-15. PubMed ID: 25740665
[TBL] [Abstract][Full Text] [Related]
35. Impact of primary stroke center certification on location of acute ischemic stroke care in Georgia.
Switzer JA; Akinwuntan A; Waller J; Nichols FT; Hess DC; Bruno A
Stroke; 2012 May; 43(5):1415-7. PubMed ID: 22363063
[TBL] [Abstract][Full Text] [Related]
36. Intravenous tissue plasminogen activator for acute ischemic stroke: feasibility, safety, and efficacy in the first year of clinical practice.
Chiu D; Krieger D; Villar-Cordova C; Kasner SE; Morgenstern LB; Bratina PL; Yatsu FM; Grotta JC
Stroke; 1998 Jan; 29(1):18-22. PubMed ID: 9445322
[TBL] [Abstract][Full Text] [Related]
37. Stroke treatment using intravenous and intra-arterial tissue plasminogen activator.
Miller J; Hartwell C; Lewandowski C
Curr Treat Options Cardiovasc Med; 2012 Jun; 14(3):273-83. PubMed ID: 22407451
[TBL] [Abstract][Full Text] [Related]
38. Intravenous thrombolytic therapy for acute ischemic stroke in Hubei, China: a survey of thrombolysis rate and barriers.
Zhou Y; Yan S; Song X; Gong Y; Li W; Wang M; Yin X; Hu B; Lu Z
BMC Neurol; 2019 Aug; 19(1):202. PubMed ID: 31438899
[TBL] [Abstract][Full Text] [Related]
39. Recanalization therapies for acute ischemic stroke.
Broderick JP
Semin Neurol; 1998; 18(4):471-84. PubMed ID: 9932618
[TBL] [Abstract][Full Text] [Related]
40. Telestroke in South Carolina.
Lazaridis C; DeSantis SM; Jauch EC; Adams RJ
J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):946-50. PubMed ID: 22196873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
